全文获取类型
收费全文 | 6990篇 |
免费 | 499篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 276篇 |
妇产科学 | 175篇 |
基础医学 | 854篇 |
口腔科学 | 70篇 |
临床医学 | 1182篇 |
内科学 | 1240篇 |
皮肤病学 | 137篇 |
神经病学 | 638篇 |
特种医学 | 208篇 |
外科学 | 719篇 |
综合类 | 178篇 |
一般理论 | 4篇 |
预防医学 | 831篇 |
眼科学 | 88篇 |
药学 | 426篇 |
中国医学 | 2篇 |
肿瘤学 | 435篇 |
出版年
2023年 | 27篇 |
2022年 | 53篇 |
2021年 | 108篇 |
2020年 | 80篇 |
2019年 | 128篇 |
2018年 | 150篇 |
2017年 | 122篇 |
2016年 | 135篇 |
2015年 | 141篇 |
2014年 | 193篇 |
2013年 | 342篇 |
2012年 | 490篇 |
2011年 | 470篇 |
2010年 | 283篇 |
2009年 | 238篇 |
2008年 | 463篇 |
2007年 | 449篇 |
2006年 | 441篇 |
2005年 | 457篇 |
2004年 | 465篇 |
2003年 | 402篇 |
2002年 | 426篇 |
2001年 | 108篇 |
2000年 | 106篇 |
1999年 | 110篇 |
1998年 | 85篇 |
1997年 | 61篇 |
1996年 | 51篇 |
1995年 | 50篇 |
1994年 | 31篇 |
1993年 | 32篇 |
1992年 | 52篇 |
1991年 | 38篇 |
1990年 | 41篇 |
1989年 | 56篇 |
1988年 | 32篇 |
1987年 | 43篇 |
1986年 | 27篇 |
1985年 | 36篇 |
1984年 | 40篇 |
1983年 | 40篇 |
1982年 | 26篇 |
1981年 | 29篇 |
1979年 | 33篇 |
1978年 | 16篇 |
1977年 | 26篇 |
1975年 | 23篇 |
1973年 | 17篇 |
1972年 | 14篇 |
1971年 | 16篇 |
排序方式: 共有7517条查询结果,搜索用时 31 毫秒
11.
Diabetic neuropathic foot ulcers and amputation 总被引:2,自引:0,他引:2
David J. Margolis MD PhD ; Lynne Allen-Taylor PhD ; Ole Hoffstad MA ; Jesse A. Berlin ScD 《Wound repair and regeneration》2005,13(3):230-236
A neuropathic foot ulcer is a severe complication of diabetes that can result in a more severe complication, a lower extremity amputation. We conducted a cohort study of 24,616 individuals with a diabetic neuropathic foot ulcer treated within a multicenter wound care network. A total of 1653 (6.7%) individuals had an amputation and 46.3% of these amputations were of a toe or ray (minor amputation). In the more than 10-year follow-up period that we studied, the percentage of those who had an amputation varied between 5.6% and 8.4%. Of those who had an amputation, the percentage that had a minor amputation increased over time from 4.0% in the earliest years to more than 60% in the later years of observation. The single most important determinant of amputation was the observation of fascia, tendon, and bone at the initial assessment. In conclusion, about 7% of those with a diabetic neuropathic foot ulcer will have an amputation and in the past 10 years there has been a remarkable increase in the number of minor as compared to major amputations. 相似文献
12.
In trauma surgery there is a particularly high proportion of patients in the age group most at risk of infection with AIDS. The result of an epidemiological study in our patients (HIV screening of all patients scheduled for surgery at a trauma center over 18 months) showed a prevalence of 0.1%. Specific therapeutic strategies must be developed to deal with the weakened immunity of HIV-infected patients. Fracture treatment in HIV-infected hemophiliacs is a special problem. Homogenous bone transplantation is described with reference to HIV. The particular danger of injury in trauma surgery is also investigated. The chain of infection is illustrated and used to demonstrate the precautions that can be taken against nosocomial HIV infections. Following infection with fluids containing HIV, specific measures must be taken. The legal aspects of HIV-antibody testing in the Federal Republic of Germany are elucidated. Finally, the problems of general preoperative HIV-antibody testing are discussed. 相似文献
13.
14.
15.
Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. 总被引:4,自引:0,他引:4
Negin Amanat Michelle McDonald Craig Godfrey Lynne Bilston David Little 《Journal of bone and mineral research》2007,22(6):867-876
We hypothesized that ZA treatment would bolster fracture repair. In a rat model for closed fracture healing, a single dose of ZA at 0, 1, or 2 wk after fracture significantly increased BMC and strength of the healed fracture. Delaying the dose (1 or 2 wk after fracture) displayed superior results compared with dosing at the time of fracture. INTRODUCTION: Bisphosphonates are known to increase bone strength and thus the resistance to fracture by decreasing osteoclastic bone resorption. These properties may enable bisphosphonates to also increase the strength of fracture repair. Zoledronic acid (ZA) is a potent bisphosphonate with a high affinity for bone mineral, allowing bolus intravenous dosing in a range of indications. In this study, we examined the application of bolus dose ZA in endochondral fracture repair. MATERIALS AND METHODS: Carbon-14 labeled ZA was used in a closed rat fracture model. Rats were divided into five treatment groups (n = 25 per group): saline control, local ZA (0.01 mg/kg), and three systemic bolus ZA groups (0.1 mg/kg) with different administration times: at fracture, 1 wk after fracture, and 2 wk after fracture. Rats were killed 6 wk postoperatively. Postmortem analyses included radiography, QCT, microCT, biomechanical testing, scintillation counting, autoradiography, and histology. RESULTS: Single-dose systemic ZA administration significantly increased callus volume, callus BMC, and mechanical strength. Perioperative treatment increased mechanical strength by 30% compared with controls (p < 0.05). Administering the systemic dose at 1 or 2 wk after fracture further increased mechanical strength compared with controls by 44% and 50%, respectively (p < 0.05). No significant differences in mechanical parameters were seen with local injection at the dose studied. Autoradiographic analysis indicated that ZA binds significantly to bone that is present at the time of administration. ZA quantification indicated that delayed administration significantly increased the uptake efficiency in the callus. Histological and microCT analysis showed that ZA treated calluses had a distinctive internal structure consisting of an intricate network of retained trabecular bone. CONCLUSIONS: The timing of a single systemic dose of ZA plays an important role in the modulation of callus properties in this rat fracture model; delaying the single dose produces a larger and stronger callus. 相似文献
16.
17.
18.
To investigate an association between colon cancer and obesity during early adulthood—a potentially important period in the etiology of this disease—the authors assembled, by computer linkage, a population-based historical cohort of 52,539 men born between 1913 and 1927 residing in Hawaii (USA), for whom weight and height had been recorded in 1942–43 and 1972. Linkage of this cohort to the Hawaii Tumor Registry resulted in the identification of 737 incident cases of colorectal cancer for 1972–86. An average of 3.8 cancer-free controls were matched to each case on month and year of birth and ethnicity of the parents. A case-control analysis in each anatomic subsite of the large bowel revealed that both early and middle-age body mass increased the risk of sigmoid cancer in men in a dose-dependent fashion. The odds ratios (OR) for sigmoid cancer for the highest compared with the lowest tertiles of Quetelet index were: 2.1 (95 percent confidence interval [CI]=1.4–3.2) and 1.7 (CI=1.1–2.5), at ages 15–29 and in prediagnostic years, respectively. These associations were additive and idependent of socioeconomic status. Men who were above the median Quetelet index in 1942 and 1972 had an OR of 2.7 (CI=1.8–4.0), compared with those who were below the median in both periods. This study provides further evidence for an association of obesity with colon cancer in men and suggests that this association is limited to the sigmoid colon and may be related to both early and late events of colon carcinogenesis.The authors are with the Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii. Address correspondence to Dr Le Marchand, Epidemiology Program, Cancer Research Center of Hawaii, 1236 Lauhala Street, Suite 407, Honolulu, HI 96813, USA. This work was supported in part by Public Health Service grant 5-R29-CA44503 and contract NO1-CN-55424 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. 相似文献
19.
20.